These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21621999)

  • 1. Peptidomimetic inhibitors of bacterial peptide deformylase.
    East SP; Ayscough A; Toogood-Johnson I; Taylor S; Thomas W
    Bioorg Med Chem Lett; 2011 Jul; 21(13):4032-5. PubMed ID: 21621999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and antibacterial activity of 3-methylenepyrrolidine formyl hydroxyamino derivatives as novel peptide deformylase inhibitors.
    Shi W; Ma H; Duan Y; Aubart K; Fang Y; Zonis R; Yang L; Hu W
    Bioorg Med Chem Lett; 2011 Feb; 21(3):1060-3. PubMed ID: 21185180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-based design of a macrocyclic inhibitor for peptide deformylase.
    Hu X; Nguyen KT; Verlinde CL; Hol WG; Pei D
    J Med Chem; 2003 Aug; 46(18):3771-4. PubMed ID: 12930137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and antibacterial activity of 2,5-dihydropyrrole formyl hydroxyamino derivatives as novel peptide deformylase inhibitors.
    Shi W; Duan Y; Qian Y; Li M; Yang L; Hu W
    Bioorg Med Chem Lett; 2010 Jun; 20(12):3592-5. PubMed ID: 20510610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acylprolinamides: a new class of peptide deformylase inhibitors with in vivo antibacterial activity.
    Axten JM; Medina JR; Blackledge CW; Duquenne C; Grant SW; Bobko MA; Peng T; Miller WH; Pinckney T; Gallagher TF; Kulkarni S; Lewandowski T; Van Aller GS; Zonis R; Ward P; Campobasso N
    Bioorg Med Chem Lett; 2012 Jun; 22(12):4028-32. PubMed ID: 22579486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide deformylase inhibitors with retro-amide scaffold: synthesis and structure-activity relationships.
    Lee SK; Choi KH; Lee SJ; Suh SW; Kim BM; Lee BJ
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4317-9. PubMed ID: 20615695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide deformylase inhibitors with non-peptide scaffold: synthesis and structure-activity relationships.
    Lee SK; Choi KH; Lee SJ; Lee JS; Park JY; Kim BM; Lee BJ
    Bioorg Med Chem Lett; 2011 Jan; 21(1):133-6. PubMed ID: 21146987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of piperazic acid peptide deformylase inhibitors with in vivo activity for respiratory tract and skin infections.
    Spletstoser JT; Dreabit J; Knox AN; Benowitz A; Campobasso N; Ward P; Cui G; Lewandowski T; McCloskey L; Aubart KM
    Bioorg Med Chem Lett; 2019 Aug; 29(16):2410-2414. PubMed ID: 31160176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationships of the peptide deformylase inhibitor BB-3497: modification of the methylene spacer and the P1' side chain.
    Davies SJ; Ayscough AP; Beckett RP; Bragg RA; Clements JM; Doel S; Grew C; Launchbury SB; Perkins GM; Pratt LM; Smith HK; Spavold ZM; Thomas SW; Todd RS; Whittaker M
    Bioorg Med Chem Lett; 2003 Aug; 13(16):2709-13. PubMed ID: 12873499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure--activity relationships of the peptide deformylase inhibitor BB-3497: modification of the P2' and P3' side chains.
    Davies SJ; Ayscough AP; Beckett RP; Clements JM; Doel S; Pratt LM; Spavold ZM; Thomas SW; Whittaker M
    Bioorg Med Chem Lett; 2003 Aug; 13(16):2715-8. PubMed ID: 12873500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and in vitro antibacterial activity of (2S)-N-(substitutedphenyl)-1-[(2R)-2-[(formylhydroxyamino)methyl]-1-oxohexyl]-2-pyrrolidinecarboxamides as potential peptide deformylase inhibitors.
    Wang Z; Zhou W
    Chem Biol Drug Des; 2009 Jan; 73(1):142-6. PubMed ID: 19152643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of moxifloxacin against community respiratory pathogens in Qatar.
    Elshafie SS; Al-Kuwari J
    Int J Antimicrob Agents; 2004 Sep; 24(3):309-10. PubMed ID: 15325441
    [No Abstract]   [Full Text] [Related]  

  • 13. Isoxazole-3-hydroxamic acid derivatives as peptide deformylase inhibitors and potential antibacterial agents.
    Calí P; Naerum L; Mukhija S; Hjelmencrantz A
    Bioorg Med Chem Lett; 2004 Dec; 14(24):5997-6000. PubMed ID: 15546716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial activity of a novel peptide deformylase inhibitor, LBM415, tested against respiratory tract and cutaneous infection pathogens: a global surveillance report (2003-2004).
    Watters AA; Jones RN; Leeds JA; Denys G; Sader HS; Fritsche TR
    J Antimicrob Chemother; 2006 May; 57(5):914-23. PubMed ID: 16549511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrocyclic inhibitors for peptide deformylase: a structure-activity relationship study of the ring size.
    Hu X; Nguyen KT; Jiang VC; Lofland D; Moser HE; Pei D
    J Med Chem; 2004 Sep; 47(20):4941-9. PubMed ID: 15369398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The structure of hormaomycin and one of its all-peptide aza-analogues in solution: syntheses and biological activities of new hormaomycin analogues.
    Reinscheid UM; Zlatopolskiy BD; Griesinger C; Zeeck A; de Meijere A
    Chemistry; 2005 May; 11(10):2929-45. PubMed ID: 15754385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro antibacterial activity of the peptide deformylase inhibitor BB-83698.
    Lofland D; Difuntorum S; Waller A; Clements JM; Weaver MK; Karlowsky JA; Johnson K
    J Antimicrob Chemother; 2004 Apr; 53(4):664-8. PubMed ID: 14973152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, antibacterial activity, and biological evaluation of formyl hydroxyamino derivatives as novel potent peptide deformylase inhibitors against drug-resistant bacteria.
    Yang S; Shi W; Xing D; Zhao Z; Lv F; Yang L; Yang Y; Hu W
    Eur J Med Chem; 2014 Oct; 86():133-52. PubMed ID: 25151577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational constraint in oxazolidinone antibacterials. Synthesis and structure-activity studies of (azabicyclo[3.1.0]hexylphenyl)oxazolidinones.
    Renslo AR; Jaishankar P; Venkatachalam R; Hackbarth C; Lopez S; Patel DV; Gordeev MF
    J Med Chem; 2005 Jul; 48(15):5009-24. PubMed ID: 16033280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antibacterial activity of 6-O-arylbutynyl ketolides with improved activity against some key erythromycin-resistant pathogens.
    Keyes RF; Carter JJ; Englund EE; Daly MM; Stone GG; Nilius AM; Ma Z
    J Med Chem; 2003 May; 46(10):1795-8. PubMed ID: 12723941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.